Ann: Mayne Pharma provides update on Women's Health pipeline, page-54

Would be good to get some clarification as to what the questions in the FDA CRL were about ,good to know the manufacturing process is worthy of approval,however being secretive about what the problem is leaves us shareholders in the dark somewhat.Disclosure information to all part owners of MYX would be the professional way to deal with what has eventuated unless of course management are embarrassed about something that they overlooked or have mishandled during the application procedures.We should hopefully hear some news surely before the end of the week/month regarding managements reply to questions raised and the new target date not long after.